4th Quarter - Report — WATKINS & EAGER PLLC for ZYNERBA PHARMACEUTICALS, INC. (2021)

Firm

WATKINS & EAGER PLLC

Client

ZYNERBA PHARMACEUTICALS, INC.

Income

$30,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Encourage Members to act favorably on matters of importance to Zynerba at their direction

Lobbyist	Covered position, as disclosed
GREGG L HARPER	Former Member of U.S. House of Representatives

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Government Issues GOV

Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites

Lobbyist	Covered position, as disclosed
GREGG L HARPER	Former Member of U.S. House of Representatives

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Pharmacy PHA

Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites

Lobbyist	Covered position, as disclosed
GREGG L HARPER	Former Member of U.S. House of Representatives

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.